Open to debate. The motion: PDE5 inhibitors will have a significant role in the treatment of BPH

Eur Urol. 2007 Nov;52(5):1523-7. doi: 10.1016/j.eururo.2007.08.025. Epub 2007 Aug 22.
No abstract available

Publication types

  • Review

MeSH terms

  • Humans
  • Male
  • Phosphodiesterase 5 Inhibitors*
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Prostatic Hyperplasia / complications
  • Prostatic Hyperplasia / drug therapy*
  • Sexual Dysfunction, Physiological / drug therapy
  • Sexual Dysfunction, Physiological / etiology
  • Treatment Outcome
  • Urination Disorders / drug therapy
  • Urination Disorders / etiology

Substances

  • Phosphodiesterase 5 Inhibitors
  • Phosphodiesterase Inhibitors